293737-80-1

Basic information

• Product Name: 2-(2-BROMO-PHENYL)-BENZOOXAZOL-5-YLAMINE
• Synonyms: TIMTEC-BB SBB009746;LABOTEST-BB LTBB000195;ART-CHEM-BB B025131;ASISCHEM T31025;2-(2-BROMO-PHENYL)-BENZOOXAZOL-5-YLAMINE;2-(2-BROMOPHENYL)-BENZOXAZOL-5-YLAMINE;AKOS BB-8054;2-(2-BROMOPHENYL)-5-BENZOXAZOLAMINE
• CAS NO: 293737-80-1
• Molecular Formula: C₁₃H₉BrN₂O
• Molecular Weight: 289.13
• Mol File: 293737-80-1.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 419.1±25.0 °C(Predicted)
• Appearance: /
• Density: 1.577±0.06 g/cm3(Predicted)
• PKA: 6.61±0.10(Predicted)
• CAS DataBase Reference: 2-(2-BROMO-PHENYL)-BENZOOXAZOL-5-YLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-BROMO-PHENYL)-BENZOOXAZOL-5-YLAMINE(293737-80-1)
• EPA Substance Registry System: 2-(2-BROMO-PHENYL)-BENZOOXAZOL-5-YLAMINE(293737-80-1)

Safety Data

• Hazardous Substances Data: 293737-80-1(Hazardous Substances Data)

Usage

General Description

2-(2-Bromo-phenyl)-benzooxazol-5-ylamine is an organic compound that belongs to the class of benzooxazoles. It consists of a benzooxazole ring attached to a 2-bromo-phenyl group and an amine group at the 5th position. 2-(2-BROMO-PHENYL)-BENZOOXAZOL-5-YLAMINE has potential applications in the pharmaceutical and agrochemical industries due to its unique chemical structure and properties. It can be used as a building block in the synthesis of various pharmacologically active compounds and as a precursor in the production of agrochemicals. Additionally, its aromatic and heterocyclic nature makes it a valuable chemical for research and development purposes in the field of organic chemistry.

Upstream product

• 137-09-7 2,4-diaminophenol dihydrochloride 
• 88-65-3 2-bromobenzoic-acid 
• 95-86-3 2,4-diaminophenol 

Downstream Products

• 332042-84-9 C₂₂H₁₃BrN₂O₃ 
• 309292-64-6 N-[2-(2-bromophenyl)-1,3-benzoxazol-5-yl]-2-phenylacetamide 

Relevant articles and documents

Discovery of 6-Arylurea-2-arylbenzoxazole and 6-Arylurea-2-arylbenzimidazole Derivatives as Angiogenesis Inhibitors: Design, Synthesis and in vitro Biological Evaluation

We embarked on a structural optimization campaign aimed at the discovery of novel anti-angiogenesis agents with previously reported imidazole kinase inhibitors as a lead compound. A library of 29 compounds was synthesized. Several title compounds exhibite

Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles

The synthesis and antimicrobial activity of a new series of 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazole derivatives 3-12 were described. The in vitro antimicrobial activity of the compounds was determined against some Gram-positi